@article{Taylor_2022,
	doi = {10.1111/dme.14814},
	url = {https://doi.org/10.1111%2Fdme.14814},
	year = 2022,
	month = {mar},
	publisher = {Wiley},
	author = {Guy S. Taylor and Andy C. Shaw and Kieran Smith and James Wason and Timothy J. McDonald and Richard A. Oram and Emma Stevenson and James A. M. Shaw and Daniel J. West},
	title = {Capturing the real-world benefit of residual $\upbeta$-cell function during clinically important time-periods in established Type 1 diabetes},
	journal = {Diabetic Medicine}
}
@article{Busby_2022,
	doi = {10.1093/rheumatology/keac139},
	url = {https://doi.org/10.1093%2Frheumatology%2Fkeac139},
	year = 2022,
	month = {mar},
	publisher = {Oxford University Press ({OUP})},
	author = {Amanda D Busby and James Wason and Arthur G Pratt and Adam Young and John D Isaacs and Elena Nikiphorou},
	title = {The role of comorbidities alongside patient and disease characteristics on long-term disease activity in {RA} using {UK} inception cohort data},
	journal = {Rheumatology}
}
@article{Mukherjee_2022,
	doi = {10.1016/j.ejca.2022.02.010},
	url = {https://doi.org/10.1016%2Fj.ejca.2022.02.010},
	year = 2022,
	month = {may},
	publisher = {Elsevier {BV}},
	volume = {166},
	pages = {270--278},
	author = {Aritra Mukherjee and James M.S. Wason and Michael J. Grayling},
	title = {When is a two-stage single-arm trial efficient? An evaluation of the impact of outcome delay},
	journal = {European Journal of Cancer}
}
@article{Li_2022,
	doi = {10.1212/wnl.0000000000200604},
	url = {https://doi.org/10.1212%2Fwnl.0000000000200604},
	year = 2022,
	month = {mar},
	publisher = {Ovid Technologies (Wolters Kluwer Health)},
	pages = {10.1212/WNL.0000000000200604},
	author = {Vivien Li and Baptiste Leurent and Frederik Barkhof and Marie Braisher and Fay Cafferty and Olga Ciccarelli and Arman Eshaghi and Emma Gray and Jennifer M. Nicholas and Mahesh Parmar and Guy Peryer and Jenny Robertson and Nigel Stallard and James Wason and Jeremy Chataway},
	title = {Designing Multi-arm Multistage Adaptive Trials for Neuroprotection in Progressive Multiple Sclerosis},
	journal = {Neurology}
}
@article{Harding_2022,
	doi = {10.1136/bmj-2021-0068229},
	url = {https://doi.org/10.1136%2Fbmj-2021-0068229},
	year = 2022,
	month = {mar},
	publisher = {{BMJ}},
	pages = {e068229},
	author = {Chris Harding and Helen Mossop and Tara Homer and Thomas Chadwick and William King and Sonya Carnell and Jan Lecouturier and Alaa Abouhajar and Luke Vale and Gillian Watson and Rebecca Forbes and Stephanie Currer and Robert Pickard and Ian Eardley and Ian Pearce and Nikesh Thiruchelvam and Karen Guerrero and Katherine Walton and Zahid Hussain and Henry Lazarowicz and Ased Ali},
	title = {Alternative to prophylactic antibiotics for the treatment of recurrent urinary tract infections in women: multicentre, open label, randomised, non-inferiority trial},
	journal = {{BMJ}}
}
